134 related articles for article (PubMed ID: 32796240)
1. Incidental Metastatic Melanoma Identified on 18F-FDOPA PET/CT With Confirmation by Histology.
Zhang-Yin J; Jublanc C; Aouidad I; Montravers F; Talbot JN
Clin Nucl Med; 2020 Oct; 45(10):817-818. PubMed ID: 32796240
[TBL] [Abstract][Full Text] [Related]
2. Limited role of carbidopa-assisted
Imperiale A; Averous G; Helali M; Taieb D; Pessaux P; Goichot B; Addeo P; Bachellier P
Ann Nucl Med; 2019 Sep; 33(9):697-707. PubMed ID: 31214959
[TBL] [Abstract][Full Text] [Related]
3. Head-to-head comparison between
Heimburger C; Veillon F; Taïeb D; Goichot B; Riehm S; Petit-Thomas J; Averous G; Cavalcanti M; Hubelé F; Chabrier G; Namer IJ; Charpiot A; Imperiale A
Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):979-987. PubMed ID: 28050631
[TBL] [Abstract][Full Text] [Related]
4. Carbidopa-assisted
Helali M; Addeo P; Heimburger C; Detour J; Goichot B; Bachellier P; Namer IJ; Taïeb D; Imperiale A
Ann Nucl Med; 2016 Nov; 30(9):659-668. PubMed ID: 27485404
[TBL] [Abstract][Full Text] [Related]
5. Role of (18) F-FDOPA PET/CT imaging in endocrinology.
Santhanam P; Taïeb D
Clin Endocrinol (Oxf); 2014 Dec; 81(6):789-98. PubMed ID: 25056984
[TBL] [Abstract][Full Text] [Related]
6. False-positive findings on 6-[18F]fluor-l-3,4-dihydroxyphenylalanine PET (
Berends AMA; Kerstens MN; Bolt JW; Links TP; Korpershoek E; de Krijger RR; Walenkamp AME; Noordzij W; van Etten B; Kats-Ugurlu G; Brouwers AH; van der Horst-Schrivers ANA
Eur J Endocrinol; 2018 Aug; 179(2):125-133. PubMed ID: 29875288
[TBL] [Abstract][Full Text] [Related]
7. The Added Diagnostic Value of
Addeo P; Poncet G; Goichot B; Leclerc L; Brigand C; Mutter D; Romain B; Namer IJ; Bachellier P; Imperiale A
J Gastrointest Surg; 2018 Apr; 22(4):722-730. PubMed ID: 29235002
[TBL] [Abstract][Full Text] [Related]
8.
Feral CC; Tissot FS; Tosello L; Fakhry N; Sebag F; Pacak K; Taïeb D
Eur J Nucl Med Mol Imaging; 2017 May; 44(5):812-821. PubMed ID: 27900521
[TBL] [Abstract][Full Text] [Related]
9. Quantitative PET studies in pretreated melanoma patients: a comparison of 6-[18F]fluoro-L-dopa with 18F-FDG and (15)O-water using compartment and noncompartment analysis.
Dimitrakopoulou-Strauss A; Strauss LG; Burger C
J Nucl Med; 2001 Feb; 42(2):248-56. PubMed ID: 11216523
[TBL] [Abstract][Full Text] [Related]
10. Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases.
Archier A; Varoquaux A; Garrigue P; Montava M; Guerin C; Gabriel S; Beschmout E; Morange I; Fakhry N; Castinetti F; Sebag F; Barlier A; Loundou A; Guillet B; Pacak K; Taïeb D
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1248-57. PubMed ID: 26637204
[TBL] [Abstract][Full Text] [Related]
11. Colorectal Adenocarcinoma Mimicking Neuroendocrine Neoplasia on 18 F-FDOPA PET/CT.
Moreau A; Isnardi V; Mognetti T; Meurgey A; Kryza D
Clin Nucl Med; 2024 Jan; 49(1):66-68. PubMed ID: 37976520
[TBL] [Abstract][Full Text] [Related]
12. 6-[F-18]fluoro-L-DOPA positron emission tomography in the imaging of Merkel cell carcinoma: preliminary report of three cases with 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography or pentetreotide-(111In) SPECT data.
Talbot JN; Kerrou K; Missoum F; Grahek D; Aide N; Lumbroso J; Montravers F
Mol Imaging Biol; 2005; 7(4):257-61. PubMed ID: 16082495
[TBL] [Abstract][Full Text] [Related]
13. The role of 18F-FDOPA and 18F-FDG-PET in the management of malignant and multifocal phaeochromocytomas.
Taïeb D; Tessonnier L; Sebag F; Niccoli-Sire P; Morange I; Colavolpe C; De Micco C; Barlier A; Palazzo FF; Henry JF; Mundler O
Clin Endocrinol (Oxf); 2008 Oct; 69(4):580-6. PubMed ID: 18394015
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of adrenal masses using 18 F-FDOPA PET/CT in patients suspected with pheochromocytoma.
Kim SJ; Park CY; Kwon H; Kim YH
Nucl Med Commun; 2024 Jan; 45(1):86-92. PubMed ID: 37901929
[TBL] [Abstract][Full Text] [Related]
15. 18F-fluorodihydroxyphenylalanine PET/CT in patients with neuroendocrine tumors of unknown origin: relation to tumor origin and differentiation.
Imperiale A; Rust E; Gabriel S; Detour J; Goichot B; Duclos B; Kurtz JE; Bachellier P; Namer IJ; Taïeb D
J Nucl Med; 2014 Mar; 55(3):367-72. PubMed ID: 24343986
[TBL] [Abstract][Full Text] [Related]
16. Early
Leroy-Freschini B; Amodru V; Addeo P; Sebag F; Vix M; Brunaud L; Klein M; Bahougne T; Bachellier P; Castinetti F; Goichot B; Chevalier E; Taieb D; Imperiale A
Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):686-695. PubMed ID: 30617961
[TBL] [Abstract][Full Text] [Related]
17. 68Ga-DOTATATE PET/CT in the Localization of Head and Neck Paragangliomas Compared with Other Functional Imaging Modalities and CT/MRI.
Janssen I; Chen CC; Taieb D; Patronas NJ; Millo CM; Adams KT; Nambuba J; Herscovitch P; Sadowski SM; Fojo AT; Buchmann I; Kebebew E; Pacak K
J Nucl Med; 2016 Feb; 57(2):186-91. PubMed ID: 26564322
[TBL] [Abstract][Full Text] [Related]
18. Comparison of 68Ga-Dotatate PET/CT and 18F-FDOPA PET/CT for the diagnosis of pancreatic neuroendocrine tumors in a MEN1 patient.
Jullien M; Reichert T; D'Anella P; Castinetti F; Barlier A; Brue T; Taieb D; Cuny T
Ann Endocrinol (Paris); 2020 Feb; 81(1):39-43. PubMed ID: 31982106
[TBL] [Abstract][Full Text] [Related]
19. Clinical and Prognostic Value of
Albano D; Familiari D; Fornito MC; Scalisi S; Laudicella R; Galia M; Grassedonio E; Ruggeri A; Ganduscio G; Messina M; Spada M; Midiri M; Alongi P
Curr Radiopharm; 2020; 13(1):42-47. PubMed ID: 31595860
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of
Hung WT; Liu CJ; Liu YL; Ko KY; Chou SW; Chang HH; Yang YL; Lu MY; Hsu WM
Pediatr Blood Cancer; 2024 Jul; 71(7):e30983. PubMed ID: 38605509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
